These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 6668099

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Renal haemodynamics after chronic treatment with labetalol and propranolol.
    Malini PL, Strocchi E, Negroni S, Ambrosioni E, Magnani B.
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):123S-126S. PubMed ID: 7093095
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Peripheral vascular effects of metoprolol, pindolol and propranolol in hypertensive patients].
    Joyal F, Bourque M, Kuchel O, Larochelle P.
    J Pharmacol; 1983 Jun; 14 Suppl 2():107-15. PubMed ID: 6138462
    [Abstract] [Full Text] [Related]

  • 27. Effects of exercise on urinary excretion of albumin and beta 2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment.
    Pedersen EB, Mogensen CE, Larsen JS.
    Scand J Clin Lab Invest; 1981 Sep; 41(5):493-8. PubMed ID: 6171861
    [Abstract] [Full Text] [Related]

  • 28. [Effect of propranolol and metoprolol on cardiorespiratory and metabolic response to exercise].
    de Barros AL, Russo AK, de Barros Neto TL, Ferreira NM, Freire E.
    Arq Bras Cardiol; 1991 Dec; 57(6):459-64. PubMed ID: 1824217
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E, Istvánffy M, Halmágyi M, Wagner M, Csukás M.
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(5):200-7. PubMed ID: 6104634
    [Abstract] [Full Text] [Related]

  • 36. [Hemodynamic differences in the effects of mepindolol-sulfate and propranolol after 4 weeks treatment under conditions of rest and physical exercise in patients with coronary heart disease (author's transl)].
    Bonelli J, Magometschnigg D, Hitzenberger G, Kaik G.
    Z Kardiol; 1978 Jan; 67(1):46-50. PubMed ID: 629073
    [Abstract] [Full Text] [Related]

  • 37. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
    Aoki K, Sato K.
    Arzneimittelforschung; 1982 Jan; 32(9):1141-5. PubMed ID: 6756418
    [Abstract] [Full Text] [Related]

  • 38. [Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient].
    Cannella G, Picotti GB, Giambelli A, Scolari F, Cesura AM, Tosoni S, Maiorca R.
    G Ital Cardiol; 1982 Jan; 12(12):884-8. PubMed ID: 6763907
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.